Peroxynitrite and inflammatory bowel disease.
McCafferty
D M
DM
Immunology Research Group Department of Physiology and Biophysics Faculty of Medicine University of Calgary Health Sciences Centre 3330 Hospital Dr. N.W. Calgary, Alberta, Canada. dmmccaff@ucalgary.ca.
D005609:Free Radicals / Q000378:metabolism; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism*; D009566:Nitrates / Q000378:metabolism*; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000378:metabolism; D052248:Nitric Oxide Synthase Type I; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; D017382:Reactive Oxygen Species / Q000378:metabolism*
D005609:Free Radicals; D009566:Nitrates; D017382:Reactive Oxygen Species; C039642:peroxynitric acid; D009569:Nitric Oxide; C496320:NOS1 protein, human; C496319:NOS2 protein, human; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III